The estimated effectiveness of the respiratory syncytial virus (RSV) among older US veterans in the 2023-2024 respiratory ...
Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...
The UKHSA is behind the new warning as a raft of illnesses, including flu, COVID, RSV, norovirus and hMPV, spread across the ...
Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study.
The study, published Jan. 20 in The Lancet Infectious Diseases, found the vaccine to be 78% effective against RSV infection, 79% effective against emergency department and urgent care visits and 80% ...
Human Metapneumovirus (HMPV) is a respiratory virus that can cause mild to severe respiratory issues. It spreads primarily ...
An Ahmedabad boy, aged four, has tested positive for human metapneumovirus, raising Gujarat's total cases to eight. The child ...
People with diabetes and obesity are at higher risk for severe respiratory illness caused by viruses, including serious ...
RSV (respiratory syncytial virus, which is a highly contagious virus ... an uptick in emergency department visits tied to these infections. "From cough to nasal congestion and even fever, it ...
Human Metapneumovirus (HMPV) is a respiratory virus that may not be on most folk’s radars, but it’s more common than you ...
Hospitals in China have been 'overwhelmed' by outbreak says WHO as NHS says people with respiratory symptoms should 'limit ...